Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Short term Debt (2016 - 2022)

Fennec Pharmaceuticals filings provide 9 years of Short term Debt readings, the most recent being $1.0 million for Q2 2022.

  • On a quarterly basis, Short term Debt changed N/A to $1.0 million in Q2 2022 year-over-year; TTM through Jun 2022 was $1.0 million, a N/A change, with the full-year FY2017 number at $167.0 million, up 505960.61% from a year prior.
  • Short term Debt hit $1.0 million in Q2 2022 for Fennec Pharmaceuticals, up from $500000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.0 million in Q2 2022 to a low of $500000.0 in Q1 2022.